Challenges and opportunities for IBD drug development: from early stage to regulatory approval

Silvio Danese, Elmer Schabel, Mark Andrew Ainsworth, Laurent Peyrin-Biroulet

Research output: Contribution to journal › Article › peer-review

Access to Document

@article{c6663d4c926648398efea96c10372986,

title = "Challenges and opportunities for IBD drug development: from early stage to regulatory approval",

author = "Silvio Danese and Elmer Schabel and Ainsworth, {Mark Andrew} and Laurent Peyrin-Biroulet",

year = "2020",

month = jul,

doi = "10.1136/gutjnl-2019-320542",

language = "English",

volume = "69",

pages = "1157--1161",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

number = "7",

}

TY - JOUR

T1 - Challenges and opportunities for IBD drug development

T2 - from early stage to regulatory approval

AU - Danese, Silvio

AU - Schabel, Elmer

AU - Ainsworth, Mark Andrew

AU - Peyrin-Biroulet, Laurent

PY - 2020/7

Y1 - 2020/7

U2 - 10.1136/gutjnl-2019-320542

DO - 10.1136/gutjnl-2019-320542

M3 - Article

C2 - 32179569

VL - 69

SP - 1157

EP - 1161

JO - Gut

JF - Gut

SN - 0017-5749

IS - 7

ER -